Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-011782
Date:2023-02-18
Issuer: CRISPR THERAPEUTICS AG (CRSP)
Original Submission Date:

Reporting Person:

KULKARNI SAMARTH
C/O CRISPR THERAPEUTICS, INC.
105 W FIRST STREET BOSTON, MA 02127

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON SHARES 2023-02-18 M 13,250 a $0.00 382,361 direct
COMMON SHARES 2023-02-21 F 6,373 d $48.26 375,988 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2023-02-18 deemed execution date M 13,250 (d) common shares 13,250 $0.00 39,750 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of crsp common shares.
f2 amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. this sale is mandated by the company's rsu settlement policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
f3 this restricted stock unit award was granted on february 18, 2022 with respect to 53,000 common shares, with (i) one quarter of the shares vesting on february 18, 2023, (ii) one quarter of the shares vesting on february 18, 2024, (iii) one quarter of the shares vesting on february 18, 2025, and (iv) one quarter of the shares vesting on february 18, 2026.
WhaleWisdom Logo

Elevate your investments